Bethesda III and IV Thyroid Nodules Managed Nonoperatively after Molecular Testing with Afirma GSC or Thyroseq v3

By sjmartinez • March 31, 2023

Kim NE, Raghunathan RS, Hughes EG, Longstaff XR, Tseng CH, Li S, Cheung DS, Gofnung YA, Famini P, Wu JX, Yeh MW, Livhits MJ. Bethesda III and IV Thyroid Nodules Managed Nonoperatively after Molecular Testing with Afirma GSC or Thyroseq v3. J Clin Endocrinol Metab. 2023 Mar 30:dgad181. doi: 10.1210/clinem/dgad181. Epub ahead of print. PMID: 36995878.

Tags: Endocrinology, General Internal Medicine, indeterminate nodules, molecular testing, nonoperative, Publications, surveillance, thyroid, thyroid cancer

Metabolic atlas of early human cortex reveals glycolytic remodeling and pentose phosphate pathway control of cell fate transitions

Mil J, Soto JA, Krall AS, Peloggia J, Frigui S, Fong OS, Sathe L, Matulionis N, Day F, Stiles L, Montales KP, Azizad DJ, Gonzalez[...]

Primary Hyperparathyroidism-Downstream Consequences of Untreated Disease

Yeh MW. Primary Hyperparathyroidism-Downstream Consequences of Untreated Disease. JAMA Surg. 2026 Jul 29. doi: 10.1001/jamasurg.2026.3047. Epub ahead of print. PMID: 42525393.

DGAT1-associated lipid-retinoid dysregulation correlates with metabolic impairment in the RPE of Stargardt disease

Dave A, Ng ESY, Jiang Z, Hu J, Tatang J, Paniagua A, Doeve J, Parikh S, Williams KJ, Stiles L, Radu RA. DGAT1-associated lipid-retinoid dysregulation[...]